Porphyria cutanea tarda affecting a rheumatoid arthritis patient treated with methotrexate: association or coincidence?
We describe the case of a 44-yr-old woman, suffering from rheumatoid arthritis for 15 yr, who developed porphyria cutanea tarda while being treated with methotrexate. The cutaneous lesions healed and the metabolic anomalies improved after a few months, despite continuing the treatment.
Chalem
P
P
Department of Rheumatology, Hôpital Cochin, Paris, France.
Ghnassia
A M
AM
Nordmann
Y
Y
Menkes
C J
CJ
D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008099:Liver / Q000378:metabolism; D008727:Methotrexate / Q000009:adverse effects*; D017119:Porphyria Cutanea Tarda / Q000139:chemically induced* / Q000145:classification / Q000378:metabolism
D018501:Antirheumatic Agents; D008727:Methotrexate